Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123207) titled 'Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: The Third Xiangya Hospital of Central South University
Condition:
Mild to Severe Crohns Disease
Intervention:
Dietary Supplement: Bacillus subtilis Capsules
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 4, 2025
Target Sample Size: 24
Countries of Recruitm...